Cosmo Pharmaceuticals S.p.A Stock Swiss Exchange
Equities
IT0004167463
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CHF | - |
04-26 | Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024 | CI |
04-25 | Cosmo Pharmaceuticals Names New CEO, Chairman | MT |
Sales 2023 | 96.72M 105M 94.63M 143M | Sales 2024 * | 262M 284M 256M 387M | Capitalization | 1.16B 1.26B 1.13B 1.71B |
---|---|---|---|---|---|
Net income 2023 | 1M 1.08M 978K 1.48M | Net income 2024 * | 111M 120M 109M 164M | EV / Sales 2023 | 8.6 x |
Net cash position 2023 | 48.44M 52.53M 47.39M 71.58M | Net cash position 2024 * | 110M 119M 108M 163M | EV / Sales 2024 * | 4.01 x |
P/E ratio 2023 |
771
x | P/E ratio 2024 * |
9.93
x | Employees | - |
Yield 2023 |
3.65% | Yield 2024 * |
2.91% | Free-Float | 44.36% |
Latest transcript on Cosmo Pharmaceuticals S.p.A
Managers | Title | Age | Since |
---|---|---|---|
Niall Donnelly
DFI | Director of Finance/CFO | 52 | 16-05-31 |
Chairman | 61 | 05-12-31 | |
Chief Tech/Sci/R&D Officer | 54 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 69 | 96-12-31 | |
Director/Board Member | 69 | 12-03-31 | |
Chairman | 61 | 05-12-31 |
1st Jan change | Capi. | |
---|---|---|
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |